Erasmus School of Health Policy & Management
Visiting fellow | Health Technology Assessment (HTA)
- knies@eshpm.eur.nl
More information
Work
- Richard Norman, Bram Roudijk, Marcel Jonker, Elly Stolk, Saskia Knies, Raoh Fang Pwu, Ciaran O’Neill, Kirsten Howard & Nancy Devlin (2025) - A Taxonomy for Assessing Whether HRQoL Value Sets Are Obsolete - PharmacoEconomics, 43 (5), 473-481 - doi: 10.1007/s40273-025-01476-1 - [link]
- Jamie Elvidge, Nick Crabb, Diana Delnoij, Saskia Knies, Douglas Lundin, François Houÿez, Juha Röning, Junfeng Wang, Li Jiu, Alastair Bennett, Yingying Zhang & Dalia Dawoud (2024) - Implementing a sandbox approach in health technology assessment: Benefits and recommendations - International Journal of Technology Assessment in Health Care, 40 (1) - doi: 10.1017/s0266462324000412 - [link]
- Anne de Bruijn, Mats van Don, Saskia Knies, Werner Brouwer & Vivian Reckers-Droog (2024) - Examining the Effect of Depicting a Patient Affected by a Negative Reimbursement Decision in Healthcare on Public Disagreement with the Decision - PharmacoEconomics, 42 (8), 879-894 - doi: 10.1007/s40273-024-01386-8 - [link]
- Ivett Jakab, Maria Dimitrova, François Houÿez, Tamás Bereczky, Miroslava Fövényes, Zorana Maravic, Ivica Belina, Christian Andriciuc, Krisztina Tóth, Oresta Piniazhko, Rok Hren, Iñaki Gutierrez-Ibarluzea, Marcin Czech, Tomas Tesar, Maciej Niewada, László Lorenzovici, Maria Kamusheva, Manoela Manova, Alexandra Savova, Zornitsa Mitkova, Konstantin Tachkov, Bertalan Németh, Zsuzsanna Ida Petykó, Dalia Dawoud, Diana Delnoij, Saskia Knies, Wim Goettsch & Zoltán Kaló (2023) - Recommendations for patient involvement in health technology assessment in Central and Eastern European countries - Frontiers in Public Health, 11 - doi: 10.3389/fpubh.2023.1176200 - [link]
- Xinyu Li, Rudolf Hoogenveen, Mohamed El Alili, Saskia Knies, Junfeng Wang, Joline W.J. Beulens, Petra J.M. Elders, Giel Nijpels, Anoukh van Giessen & Talitha L. Feenstra (2023) - Cost-Effectiveness of SGLT2 Inhibitors in a Real-World Population: A MICADO Model-Based Analysis Using Routine Data from a GP Registry - PharmacoEconomics, 41 (10), 1249-1262 - doi: 10.1007/s40273-023-01286-3 - [link]
- , Joost J. Enzing, Frédérique C.W. van Krugten, Iryna Sabat, Sebastian Neumann-Böhme, Bert Boer, Saskia Knies & Werner B.F. Brouwer (2022) - Psychometric evaluation of the Mental Health Quality of Life (MHQoL) instrument in seven European countries - Health and Quality of Life Outcomes, 20 (1) - doi: 10.1186/s12955-022-02041-6 - [link]
- Joost J. Enzing, Saskia Knies, Jop Engel, Maarten J. IJzerman, Beate Sander, Rick Vreman, Bert Boer & Werner B.F. Brouwer (2022) - Do Health Technology Assessment organisations consider manufacturers’ costs in relation to drug price?: A study of reimbursement reports - Cost Effectiveness and Resource Allocation, 20 (1) - doi: 10.1186/s12962-022-00383-y - [link]
- Joost J. Enzing, Sebastian Himmler, Saskia Knies & Werner B.F. Brouwer (2022) - Do Profit Margins of Pharmaceuticals Influence Reimbursement Decisions?: A Discrete Choice Experiment Among Dutch Healthcare Decision Makers - Value in Health, 25 (2), 222-229 - doi: 10.1016/j.jval.2021.08.007 - [link]
- Joost J Enzing, Saskia Knies, Bert Boer & Werner B F Brouwer (2021) - Broadening the application of health technology assessment in the Netherlands: a worthwhile destination but not an easy ride? - Health Economics, Policy and Law, 16 (4), 440-456 - doi: 10.1017/s1744133120000237 - [link]
- Rick A. Vreman, Joost W. Geenen, Saskia Knies, Aukje K. Mantel-Teeuwisse, Hubert G.M. Leufkens & Wim G. Goettsch (2021) - Comment on “Deterministic Sensitivity Analysis Under Ignorance” - PharmacoEconomics, 39 (10), 1199 - doi: 10.1007/s40273-021-01086-7 - [link]
